BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 222 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,366,116 | +264.8% | 68,344 | +221.0% | 0.01% | +333.3% |
| Q1 2024 | $2,019,380 | +719.3% | 21,288 | +445.8% | 0.00% | +200.0% |
| Q2 2023 | $246,480 | -68.3% | 3,900 | -77.5% | 0.00% | -91.7% |
| Q1 2023 | $778,327 | +127.8% | 17,300 | +121.8% | 0.01% | +71.4% |
| Q4 2022 | $341,718 | +29.4% | 7,800 | +49.0% | 0.01% | 0.0% |
| Q2 2022 | $264,000 | -84.1% | 5,234 | -66.1% | 0.01% | -86.3% |
| Q4 2021 | $1,656,000 | +707.8% | 15,461 | +488.3% | 0.05% | +10.9% |
| Q2 2020 | $205,000 | -58.2% | 2,628 | -68.7% | 0.05% | -57.4% |
| Q1 2020 | $491,000 | -62.4% | 8,400 | -48.5% | 0.11% | +28.6% |
| Q4 2019 | $1,306,000 | +106.6% | 16,300 | +89.5% | 0.08% | +121.1% |
| Q3 2019 | $632,000 | – | 8,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |